Alterações vasculares no paciente COVID
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | por |
Título da fonte: | Repositório do Centro Universitário Braz Cubas |
Texto Completo: | https://repositorio.cruzeirodosul.edu.br/handle/123456789/4180 |
Resumo: | Severe acute respiratory syndrome coronavirus (SARS-COV-2), leads to changes in our body that cause multisystem lesions, generating dysfunction, with evidence to suggest that endothelial injury mediated by SARS-COV-2 is an effector factor of the virus. These multisystemic lesions can generate multiple inflammatory responses, this being the host's defense mechanism in an attempt to eliminate the pathogen, this inflammatory response also occurs in the endothelium of the vessels in a significant way. In the course of this work, more will be presented about the disease in its vascular scope and its main vascular complications, because, as it is a disease that has reached the population worldwide and so quickly, it is necessary to discuss more about this topic sorelevant for the improvement management for these patients. The objective is to identify the main vascular complications in patients with COVID-19. The present work is an integrative literature review study, which will evaluate clinical trial publications, systematic literature review and clinical practice guides indexed in the SciELO, Pubmed and Uptodate databases, published between the years 2019 to 2021, and that meet the inclusion criteria. Data collection will be carried out through an adaptation of the instrument proposed by Ursi, which will address the following items: Identification of the original article, methodological characteristics of the study, evaluation of the interventions carried out and the results. Data analysis and synthesis was performed by adapting an instrument proposed by Ursi, which includes the following aspects: Research name; study design; methodological detailing; sample detailing; intervention employed; results; recommendations / conclusions. The results found show that the viral infection is usually self-limited and benign, however, some patients progress to the severe form of the disease, resulting in a hyperactivation of the immune system, generating hyperinflammation and hypercoability, which can generate venous and arterial thrombosis, as well as Multiple organ failure in patients with the severe form of COVID. It is concluded that these patients have a hyperactivation of the immune system, and that a group of patients is predisposed to a hyperinflammatory state. In addition, it was observed that these patients have a state of hypercoability that is not fully understood, requiring further studies to understand this. |
id |
CUB_4d15927fbcf0f5d46993486b592bb21e |
---|---|
oai_identifier_str |
oai:repositorio.cruzeirodosul.edu.br:123456789/4180 |
network_acronym_str |
CUB |
network_name_str |
Repositório do Centro Universitário Braz Cubas |
repository_id_str |
|
spelling |
Alterações vasculares no paciente COVIDCovidvascularinflamatóriaendotélioCNPQ::CIENCIAS DA SAUDE::MEDICINASevere acute respiratory syndrome coronavirus (SARS-COV-2), leads to changes in our body that cause multisystem lesions, generating dysfunction, with evidence to suggest that endothelial injury mediated by SARS-COV-2 is an effector factor of the virus. These multisystemic lesions can generate multiple inflammatory responses, this being the host's defense mechanism in an attempt to eliminate the pathogen, this inflammatory response also occurs in the endothelium of the vessels in a significant way. In the course of this work, more will be presented about the disease in its vascular scope and its main vascular complications, because, as it is a disease that has reached the population worldwide and so quickly, it is necessary to discuss more about this topic sorelevant for the improvement management for these patients. The objective is to identify the main vascular complications in patients with COVID-19. The present work is an integrative literature review study, which will evaluate clinical trial publications, systematic literature review and clinical practice guides indexed in the SciELO, Pubmed and Uptodate databases, published between the years 2019 to 2021, and that meet the inclusion criteria. Data collection will be carried out through an adaptation of the instrument proposed by Ursi, which will address the following items: Identification of the original article, methodological characteristics of the study, evaluation of the interventions carried out and the results. Data analysis and synthesis was performed by adapting an instrument proposed by Ursi, which includes the following aspects: Research name; study design; methodological detailing; sample detailing; intervention employed; results; recommendations / conclusions. The results found show that the viral infection is usually self-limited and benign, however, some patients progress to the severe form of the disease, resulting in a hyperactivation of the immune system, generating hyperinflammation and hypercoability, which can generate venous and arterial thrombosis, as well as Multiple organ failure in patients with the severe form of COVID. It is concluded that these patients have a hyperactivation of the immune system, and that a group of patients is predisposed to a hyperinflammatory state. In addition, it was observed that these patients have a state of hypercoability that is not fully understood, requiring further studies to understand this.A síndrome respiratória aguda grave do coronavírus (SARS-COV-2), leva a alterações no nosso organismo que causam lesões multissistêmicas, gerando disfunção, com evidências que sugerem que a lesão endotelial mediada pelo SARS-COV-2 é um fator efetor do vírus. Essas lesões multissistêmicas, podem gerar múltiplas respostas inflamatórias, sendo esse o mecanismo de defesa do hospedeiro na tentativa de eliminar o patógeno, essa resposta inflamatória também ocorre no endotélio dos vasos de forma significativa. No decorrer desse trabalho será apresentado sobre a doença no seu âmbito vascular e suas principais complicações vasculares, pois, por ser uma doença que atingiu a população a nível mundial e tão rapidamente, se é necessário discutir mais sobre esse tema tão pertinente para a melhora do manejo para com esses pacientes. O objetivo é identificaras principais complicações vasculares no paciente portador da COVID-19. O presente trabalhose tratade um estudo do tipo revisão integrativa de literatura, que avaliarápublicações do tipo ensaio clínico, revisão sistemática de literatura e guias de prática clínica indexadas nos bancos de dados da SciELO, Pubmed e Uptodate, publicadas entre os anos de 2019 a 2021, e que preencham aos critérios de inclusão. A coleta dos dados será realizada através de uma adaptação do instrumento proposto por Ursi que abordará os seguintes itens: Identificação do artigo original, características metodológicas do estudo, avaliação das intervenções realizadas e dos resultados. A análise e síntese dos dados foirealizada mediante adaptação de um instrumento proposto por Ursi que contempla os seguintes aspectos: Nome da pesquisa; delineamento de estudo; detalhamento metodológico; detalhamento amostral; intervenção empregada; resultados; recomendações / conclusões.Os resultados encontrados mostram que a infecção viral geralmente é autolimitada e benigna, porém,alguns pacientes evoluem para a forma grave da doença,acarretandoem uma hiperativação do sistema imunológico, gerando uma hiperinflamação e uma hipercoabilidade, podendo gerar tromboses venosas e arteriais, assim como falênciamultiplade órgãos em pacientes acometidos com aforma grave da COVID.Conclui-seque esses pacientes possuem uma hiperativaçãodo sistema imunológico, e que um grupo de pacientes tem predisposição para um estado hiperinflamatório. Além disso, foi observado que essespacientes possuem um estado de hipercoabilidade que não está totalmente entendido, necessitando de mais estudos para a compreensão deste.Centro Universitário de João PessoaBrasilUNIPÊBrito, Lizandro Leitehttp://lattes.cnpq.br/2299749731397831Calado Neto, Nivaldo Alves2022-12-06T15:06:11Z2022-12-092022-12-06T15:06:11Z2022-06-17info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisapplication/pdfCALADO NETO, Nivaldo Alves. Alterações vasculares no paciente COVID. 26 P. Trabalho de conclusão de curso (Graduação em Medicina) - Centro Universitário de João Pessoa – UNIPÊ, João Pessoa, 2022.https://repositorio.cruzeirodosul.edu.br/handle/123456789/4180porBecker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020 Oct;50(3):499-511. doi: 10.1007/s11239-020-02230-4. PMID: 32700024; PMCID: PMC7373848. Disponível em: https://link.springer.com/article/10.1007%2Fs11239-020-02230-4. Acesso em: 08 dez 2021.BRANDÃO, Simoneet al. COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica.Jornal Vascular Brasileiro, 2020. DOI https://doi.org/10.1590/1677-5449.200131. Disponível em: https://www.scielo.br/j/jvb/a/j7v6NtBNvGSGGTDz38wnRxm/?lang=pt#. Acesso em: 20 out. 2021.CREPALDI, Mariaet al. Terminalidade, morte e luto na pandemia de COVID-19: demandas psicológicas emergentes e implicações práticas.Seção Temática: Contribuições da Psicologia no Contexto da Pandemia da COVID-19, [s. l.], 1 jun. 2020. DOI https://doi.org/10.1590/1982-0275202037e200090. Disponível em: https://www.scielo.br/j/estpsi/a/LRmfcnxMXwrbCtWSxJKwBkm/?lang=pt. Acesso em: 6 set. 2021.CUKER, Adamet al. COVID-19: Hypercoagulability.COVID-19: Hypercoagulability, [s. l.], 3 set. 2021. Disponível em: https://www.uptodate.com/contents/covid-19-hypercoagulability?search=vascular%20covid&source=search_result&selectedTitle=5~150&usage_type=default&display_rank=5#H1322232430. Acesso em: 14 set. 2021.Jean M. Connors, Jerrold H. Levy; COVID-19 and its implications for thrombosis and anticoagulation.Blood2020; 135 (23): 2033–2040. doi:https://doi.org/10.1182/blood.2020006000KIM, Jaeet al. Immunopathogenesis and treatment of cytokine storm in COVID-19.Theranostics, [s. l.], 1 jan. 2021. DOI doi:10.7150/thno.49713. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33391477/. Acesso em: 19 out. 2021LEVY, Jerroldet al. Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together.Arteriosclerosis, Thrombosis, and Vascular Biology, [s. l.], 1 abr. 2021. DOI 10.1161/ATVBAHA.121.316101. Disponível em: https://www.ahajournals.org/doi/10.1161/ATVBAHA.121.316101. Acesso em: 1 set. 2021.Nascimento CR, Santos JM, Brito SBP, Tenório PP. Quais são os mecanismos celulares relacionados aos eventos tromboembólicos em pacientes com COVID-19?J Vasc Bras. 2021;20: e20210020.https://doi.org/10.1590/1677-5449.210020OROPALLO, Alisha et al. COVID-19: Issues related to wound care and telehealth management. [s. l.], 2021. Disponível em: https://www.uptodate.com/contents/covid-19-issues-related-to-wound-care-and-telehealth-management?search=covid%20vasculite&source=search_result&selectedTitle=8~150&usage_type=default&display_rank=8. Acesso em: 10 dez 2021.SIDDIQI, Hasanet al. COVID-19 -A vascular disease.Trends Cardiovasc Med, [s. l.], 14 out. 2020. DOI 10.1016/j.tcm.2020.10.005. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33068723/. Acesso em: 17 set. 2021. 19SIDDIQI, Hasanet al. Vascular injury in acute infections and COVID-19: everything old is new again.Trends Cardiovasc Med, [s. l.], 2 nov. 2020. DOI 10.1016/j.tcm.2020.10.011. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33129973/. Acesso em: 15 set. 2021.Sivaloganathan, H., Ladikou, E.E. and Chevassut, T. (2020), COVID-19 mortality in patients on anticoagulants and antiplatelet agents. Br J Haematol, 190: e192-e195.https://doi.org/10.1111/bjh.16968WOHLAUER, Max et al. COVID-19: Acute limb ischemia. [s. l.], 2021. Disponível em: https://www.uptodate.com/contents/covid-19-acute-limb-ischemia#:~:text=Acute%20limb%20ischemia%20(ALI)%2C%20the%20sudden%20decrease%20in%20perfusion,2019%20(COVID%2D19). Acesso em 13 dez. 2021.Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.JAMA Intern Med.2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994info:eu-repo/semantics/openAccessreponame:Repositório do Centro Universitário Braz Cubasinstname:Centro Universitário Braz Cubas (CUB)instacron:CUB2022-12-06T15:10:19Zoai:repositorio.cruzeirodosul.edu.br:123456789/4180Repositório InstitucionalPUBhttps://repositorio.brazcubas.edu.br/oai/requestbibli@brazcubas.edu.bropendoar:2022-12-06T15:10:19Repositório do Centro Universitário Braz Cubas - Centro Universitário Braz Cubas (CUB)false |
dc.title.none.fl_str_mv |
Alterações vasculares no paciente COVID |
title |
Alterações vasculares no paciente COVID |
spellingShingle |
Alterações vasculares no paciente COVID Calado Neto, Nivaldo Alves Covid vascular inflamatória endotélio CNPQ::CIENCIAS DA SAUDE::MEDICINA |
title_short |
Alterações vasculares no paciente COVID |
title_full |
Alterações vasculares no paciente COVID |
title_fullStr |
Alterações vasculares no paciente COVID |
title_full_unstemmed |
Alterações vasculares no paciente COVID |
title_sort |
Alterações vasculares no paciente COVID |
author |
Calado Neto, Nivaldo Alves |
author_facet |
Calado Neto, Nivaldo Alves |
author_role |
author |
dc.contributor.none.fl_str_mv |
Brito, Lizandro Leite http://lattes.cnpq.br/2299749731397831 |
dc.contributor.author.fl_str_mv |
Calado Neto, Nivaldo Alves |
dc.subject.por.fl_str_mv |
Covid vascular inflamatória endotélio CNPQ::CIENCIAS DA SAUDE::MEDICINA |
topic |
Covid vascular inflamatória endotélio CNPQ::CIENCIAS DA SAUDE::MEDICINA |
description |
Severe acute respiratory syndrome coronavirus (SARS-COV-2), leads to changes in our body that cause multisystem lesions, generating dysfunction, with evidence to suggest that endothelial injury mediated by SARS-COV-2 is an effector factor of the virus. These multisystemic lesions can generate multiple inflammatory responses, this being the host's defense mechanism in an attempt to eliminate the pathogen, this inflammatory response also occurs in the endothelium of the vessels in a significant way. In the course of this work, more will be presented about the disease in its vascular scope and its main vascular complications, because, as it is a disease that has reached the population worldwide and so quickly, it is necessary to discuss more about this topic sorelevant for the improvement management for these patients. The objective is to identify the main vascular complications in patients with COVID-19. The present work is an integrative literature review study, which will evaluate clinical trial publications, systematic literature review and clinical practice guides indexed in the SciELO, Pubmed and Uptodate databases, published between the years 2019 to 2021, and that meet the inclusion criteria. Data collection will be carried out through an adaptation of the instrument proposed by Ursi, which will address the following items: Identification of the original article, methodological characteristics of the study, evaluation of the interventions carried out and the results. Data analysis and synthesis was performed by adapting an instrument proposed by Ursi, which includes the following aspects: Research name; study design; methodological detailing; sample detailing; intervention employed; results; recommendations / conclusions. The results found show that the viral infection is usually self-limited and benign, however, some patients progress to the severe form of the disease, resulting in a hyperactivation of the immune system, generating hyperinflammation and hypercoability, which can generate venous and arterial thrombosis, as well as Multiple organ failure in patients with the severe form of COVID. It is concluded that these patients have a hyperactivation of the immune system, and that a group of patients is predisposed to a hyperinflammatory state. In addition, it was observed that these patients have a state of hypercoability that is not fully understood, requiring further studies to understand this. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-12-06T15:06:11Z 2022-12-09 2022-12-06T15:06:11Z 2022-06-17 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
CALADO NETO, Nivaldo Alves. Alterações vasculares no paciente COVID. 26 P. Trabalho de conclusão de curso (Graduação em Medicina) - Centro Universitário de João Pessoa – UNIPÊ, João Pessoa, 2022. https://repositorio.cruzeirodosul.edu.br/handle/123456789/4180 |
identifier_str_mv |
CALADO NETO, Nivaldo Alves. Alterações vasculares no paciente COVID. 26 P. Trabalho de conclusão de curso (Graduação em Medicina) - Centro Universitário de João Pessoa – UNIPÊ, João Pessoa, 2022. |
url |
https://repositorio.cruzeirodosul.edu.br/handle/123456789/4180 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis. 2020 Oct;50(3):499-511. doi: 10.1007/s11239-020-02230-4. PMID: 32700024; PMCID: PMC7373848. Disponível em: https://link.springer.com/article/10.1007%2Fs11239-020-02230-4. Acesso em: 08 dez 2021.BRANDÃO, Simoneet al. COVID-19 grave: entenda o papel da imunidade, do endotélio e da coagulação na prática clínica.Jornal Vascular Brasileiro, 2020. DOI https://doi.org/10.1590/1677-5449.200131. Disponível em: https://www.scielo.br/j/jvb/a/j7v6NtBNvGSGGTDz38wnRxm/?lang=pt#. Acesso em: 20 out. 2021.CREPALDI, Mariaet al. Terminalidade, morte e luto na pandemia de COVID-19: demandas psicológicas emergentes e implicações práticas.Seção Temática: Contribuições da Psicologia no Contexto da Pandemia da COVID-19, [s. l.], 1 jun. 2020. DOI https://doi.org/10.1590/1982-0275202037e200090. Disponível em: https://www.scielo.br/j/estpsi/a/LRmfcnxMXwrbCtWSxJKwBkm/?lang=pt. Acesso em: 6 set. 2021.CUKER, Adamet al. COVID-19: Hypercoagulability.COVID-19: Hypercoagulability, [s. l.], 3 set. 2021. Disponível em: https://www.uptodate.com/contents/covid-19-hypercoagulability?search=vascular%20covid&source=search_result&selectedTitle=5~150&usage_type=default&display_rank=5#H1322232430. Acesso em: 14 set. 2021.Jean M. Connors, Jerrold H. Levy; COVID-19 and its implications for thrombosis and anticoagulation.Blood2020; 135 (23): 2033–2040. doi:https://doi.org/10.1182/blood.2020006000KIM, Jaeet al. Immunopathogenesis and treatment of cytokine storm in COVID-19.Theranostics, [s. l.], 1 jan. 2021. DOI doi:10.7150/thno.49713. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33391477/. Acesso em: 19 out. 2021LEVY, Jerroldet al. Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together.Arteriosclerosis, Thrombosis, and Vascular Biology, [s. l.], 1 abr. 2021. DOI 10.1161/ATVBAHA.121.316101. Disponível em: https://www.ahajournals.org/doi/10.1161/ATVBAHA.121.316101. Acesso em: 1 set. 2021.Nascimento CR, Santos JM, Brito SBP, Tenório PP. Quais são os mecanismos celulares relacionados aos eventos tromboembólicos em pacientes com COVID-19?J Vasc Bras. 2021;20: e20210020.https://doi.org/10.1590/1677-5449.210020OROPALLO, Alisha et al. COVID-19: Issues related to wound care and telehealth management. [s. l.], 2021. Disponível em: https://www.uptodate.com/contents/covid-19-issues-related-to-wound-care-and-telehealth-management?search=covid%20vasculite&source=search_result&selectedTitle=8~150&usage_type=default&display_rank=8. Acesso em: 10 dez 2021.SIDDIQI, Hasanet al. COVID-19 -A vascular disease.Trends Cardiovasc Med, [s. l.], 14 out. 2020. DOI 10.1016/j.tcm.2020.10.005. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33068723/. Acesso em: 17 set. 2021. 19SIDDIQI, Hasanet al. Vascular injury in acute infections and COVID-19: everything old is new again.Trends Cardiovasc Med, [s. l.], 2 nov. 2020. DOI 10.1016/j.tcm.2020.10.011. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33129973/. Acesso em: 15 set. 2021.Sivaloganathan, H., Ladikou, E.E. and Chevassut, T. (2020), COVID-19 mortality in patients on anticoagulants and antiplatelet agents. Br J Haematol, 190: e192-e195.https://doi.org/10.1111/bjh.16968WOHLAUER, Max et al. COVID-19: Acute limb ischemia. [s. l.], 2021. Disponível em: https://www.uptodate.com/contents/covid-19-acute-limb-ischemia#:~:text=Acute%20limb%20ischemia%20(ALI)%2C%20the%20sudden%20decrease%20in%20perfusion,2019%20(COVID%2D19). Acesso em 13 dez. 2021.Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.JAMA Intern Med.2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Centro Universitário de João Pessoa Brasil UNIPÊ |
publisher.none.fl_str_mv |
Centro Universitário de João Pessoa Brasil UNIPÊ |
dc.source.none.fl_str_mv |
reponame:Repositório do Centro Universitário Braz Cubas instname:Centro Universitário Braz Cubas (CUB) instacron:CUB |
instname_str |
Centro Universitário Braz Cubas (CUB) |
instacron_str |
CUB |
institution |
CUB |
reponame_str |
Repositório do Centro Universitário Braz Cubas |
collection |
Repositório do Centro Universitário Braz Cubas |
repository.name.fl_str_mv |
Repositório do Centro Universitário Braz Cubas - Centro Universitário Braz Cubas (CUB) |
repository.mail.fl_str_mv |
bibli@brazcubas.edu.br |
_version_ |
1798311341320044544 |